New stitch device takes on amplatzer in battle to prevent second strokes
NCT ID NCT04339699
First seen Apr 05, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This study tests a new device called NobleStitch EL against an already approved device (Amplatzer) for closing a small hole in the heart called a PFO. The goal is to see which one works better at preventing another stroke in people aged 18-60 who have already had a stroke from an unknown cause. Participants will be followed for up to 5 years to check for stroke recurrence and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE, ISCHEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ospedale S. Eugenio
RECRUITINGRome, Lazio, 00144, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
TMC HealthCare
RECRUITINGTucson, Arizona, 85712, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.